Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Sprung

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Critical Care Medicine|August 1, 1993
Monoclonal antibodies, new technologies, and critical care medicineC L Sprung, L A Eidelman
Intensive Care Medicine|October 1, 1996
Worldwide similarities and differences in the foregoing of life-sustaining treatmentsC L Sprung, L A Eidelman
Chest|November 1, 1988
The pulmonary artery catheter. The debate continuesW J Sibbald, C L Sprung
Critical Care Clinics|April 1, 1997
International perspectives on ethics in critical careD J Nyman, C L Sprung
Intensive Care Medicine|December 29, 2000
End-of-life decision making in the intensive care unitD J Nyman, C L Sprung
Critical Care Medicine|August 1, 1994
Why have new effective therapies for sepsis not been developed?L A Eidelman, C L Sprung
World Journal of Surgery|April 1, 1987
Corticosteroids, nonsteroidal anti-inflammatory drugs, and naloxone in the sepsis syndromeW M Long, C L Sprung
New Horizons (Baltimore, Md.)|August 1, 1997
Ethical issues of clinical trials for the pulmonary artery catheterC L Sprung, L A Eidelman
New Horizons (Baltimore, Md.)|August 1, 1997
The issue of a U.S. Food and Drug Administration moratorium on the use of the pulmonary artery catheterC L Sprung, L A Eidelman
Critical Care Medicine|July 1, 1990
Responsibilities of critical care professionals in setting medical policies for foregoing life-sustaining treatmentsC L Sprung, R C Raphaely
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Critical Care Medicine|August 1, 1993
Monoclonal antibodies, new technologies, and critical care medicineC L Sprung, L A Eidelman
Intensive Care Medicine|October 1, 1996
Worldwide similarities and differences in the foregoing of life-sustaining treatmentsC L Sprung, L A Eidelman
Chest|November 1, 1988
The pulmonary artery catheter. The debate continuesW J Sibbald, C L Sprung
Critical Care Clinics|April 1, 1997
International perspectives on ethics in critical careD J Nyman, C L Sprung
Intensive Care Medicine|December 29, 2000
End-of-life decision making in the intensive care unitD J Nyman, C L Sprung
Critical Care Medicine|August 1, 1994
Why have new effective therapies for sepsis not been developed?L A Eidelman, C L Sprung
World Journal of Surgery|April 1, 1987
Corticosteroids, nonsteroidal anti-inflammatory drugs, and naloxone in the sepsis syndromeW M Long, C L Sprung
New Horizons (Baltimore, Md.)|August 1, 1997
Ethical issues of clinical trials for the pulmonary artery catheterC L Sprung, L A Eidelman
New Horizons (Baltimore, Md.)|August 1, 1997
The issue of a U.S. Food and Drug Administration moratorium on the use of the pulmonary artery catheterC L Sprung, L A Eidelman
Critical Care Medicine|July 1, 1990
Responsibilities of critical care professionals in setting medical policies for foregoing life-sustaining treatmentsC L Sprung, R C Raphaely
Pageof 13